CTRI Number |
CTRI/2024/01/062089 [Registered on: 31/01/2024] Trial Registered Prospectively |
Last Modified On: |
30/01/2024 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Nalbuphine vs fentanyl as additive to main drug bupivacaine in spinal anaesthesia. |
Scientific Title of Study
|
Comparison of intrathecal nalbuphine and fentanyl as adjuvants to bupivacaine in spinal anaesthesia in patients undergoing lower limb surgeries. |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Virendra Nimbalkar |
Designation |
Post graduate trainee |
Affiliation |
Silchar medical college and hospital |
Address |
Department of anesthesia and critical care, Silchar medical college and hospital, Silchar.
Cachar ASSAM 788014 India |
Phone |
9673240044 |
Fax |
|
Email |
virunimbalkar@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Suneeta Dutta |
Designation |
Head of department |
Affiliation |
Silchar medical college and hospital |
Address |
Department of anesthesia and critical care, Silchar medical college and hospital, Silchar.
Cachar ASSAM 788014 India |
Phone |
9435074110 |
Fax |
|
Email |
drsuneetadutta@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Suneeta Dutta |
Designation |
Head of department |
Affiliation |
Silchar medical college and hospital |
Address |
Department of anesthesia and critical care, Silchar medical college and hospital, Silchar.
Cachar ASSAM 788014 India |
Phone |
9435074110 |
Fax |
|
Email |
drsuneetadutta@gmail.com |
|
Source of Monetary or Material Support
|
Silchar medical college and hospital, Silchar, Cachar, Assam Pin-788014 |
|
Primary Sponsor
|
Name |
Dr Virendra Nimbalkar |
Address |
Department of anesthesia and critical care, Silchar medical college and hospital, Silchar,788014 |
Type of Sponsor |
Other [Self] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Virendra Nimbalkar |
Silchar medical college and hospital |
Orthopedics department Cachar ASSAM |
9673240044
virunimbalkar@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee of Silchar Medical College and Hospital |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Healthy Human Volunteers |
healthy patients undergoing lower limb surgeries |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Intrathecal fentanyl as adjuvants to heavy bupivacaine in spinal anesthesia in patients undergoing lower limb surgeries. |
The solution will be prepared in a five ml syringe which will contain, a) 3ml(15mg)of 0.5% Bupivacaine heavy+0.5ml fentanyl(25µg).The above combination of drugs was given via intrathecal subarachnoid route with the patient in standard sitting position with a 25Gauge Quincke needle at L3-L4 intervertebral space using midline approach maintaining strict aseptic condition.Taking into consideration the time of spinal injection as zero, all other durations were calculated accordingly and all measurements will be recorded from this point upto 3 hours postop . Following subarachnoid block, patients will be made to lie supine. |
Intervention |
Intrathecal nalbuphine as adjuvants to heavy bupivacaine in spinal anesthesia in patients undergoing lower limb surgeries. |
The solution will be
prepared in a five ml syringe
which will contain, a) 3ml(15mg)of 0.5% Bupivacaine
heavy+0.5ml Nalbuphine(0.5mg).The above combination of drugs was given via intrathecal subarachnoid route with the patient in standard sitting position with a 25Gauge Quincke needle at L3-L4 intervertebral space using midline approach maintaining strict aseptic condition. Taking into consideration the time of spinal injection as zero, all other durations were calculated accordingly and all measurements
will be recorded from this point up to 3 hours postop. Following subarachnoid block, patients will be made to lie supine. |
|
Inclusion Criteria
|
Age From |
25.00 Year(s) |
Age To |
65.00 Year(s) |
Gender |
Both |
Details |
1.American society of anaesthesiologist(ASA) status I and II
2.Age 25-65 years
3.both genders. |
|
ExclusionCriteria |
Details |
1.Patients with contraindication to spinal anaesthesia
2.Pre-existing neurological deficits
3.Patients with history of allergy to study drugs
4.Pregnant patients. |
|
Method of Generating Random Sequence
|
Other |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To evaluate & compare the following factors in
two groups-intrathecal nalbuphine &
intrathecal fentanyl as an adjuvant to
hyperbaric bupivacaine in lower limb
surgeries with respect to:
1. Sensory & motor blockade -onset & duration |
Time at which intrathecal drug is administered is
T0, followed by T1 at 1min,T2 at 2 min,T3 at 3 min interval......till intraoperative period followed
by time required for regaining of sensory and
motor sensation in postoperative period. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Duration of analgesia |
perioperative to postoperative period |
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
09/02/2024 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Spinal anesthesia remains a popular method of anesthesia for a wide range of surgeries due to its easiness ,safety features and newer addition drugs with less side effects and more benefits for certain patient populations. However, it is also frequently associated with undesirable effects such as hypotension, bradycardia, and shivering. Rarely, it may cause severe bradycardia and cardiac arrest. Adjuvants or additives are often used with local anesthetics for its synergistic effect by prolonging the duration of sensory-motor block, minimize side effects and limiting the cumulative dose requirement of local anesthetics. Opioids are the time honoured drugs which have been used for this purpose. Nalbuphine is an agonist-antagonist opioid synthesized to produce analgesia without any unwanted µ agonist side effects like respiratory depression, undesirable sedation, nausea, vomiting and urinary retention. Fentanyl, a synthetic opioid, has fast onset of action following intrathecal administration due to its high lipid soluble nature. It does not tend to migrate to the fourth ventricle in sufficient concentration to cause delayed respiratory depression when administered intrathecally. In this study. Adjuvants are added to prolong post operative analgesia to increase duration of analgesia and to limit the side effects of increased dose of local anesthetics on hemodynamics. |